Cargando…
A Dual Swine Challenge With Porcine Circovirus Type 2 (PCV2) and Mycoplasma hyopneumoniae Used to Compare a Combination of Mixable Monovalent PCV2 and Monovalent M. hyopneumoniae Vaccines With a Ready-to Use PCV2 and M. hyopneumoniae Bivalent Vaccine
The present study evaluated the efficacy of swine vacciation using a combination of mixable monovalents for porcine circovirus type 2 (PCV2) and Mycoplasma hyopneumoniae against a ready-to-use bivalent vaccine under experimental conditions. Pigs at 21 days of age were administered either a combinati...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7492382/ https://www.ncbi.nlm.nih.gov/pubmed/32984414 http://dx.doi.org/10.3389/fvets.2020.00579 |
_version_ | 1783582368060145664 |
---|---|
author | Yang, Siyeon Oh, Taehwan Park, Kee Hwan Cho, Hyejean Chae, Chanhee |
author_facet | Yang, Siyeon Oh, Taehwan Park, Kee Hwan Cho, Hyejean Chae, Chanhee |
author_sort | Yang, Siyeon |
collection | PubMed |
description | The present study evaluated the efficacy of swine vacciation using a combination of mixable monovalents for porcine circovirus type 2 (PCV2) and Mycoplasma hyopneumoniae against a ready-to-use bivalent vaccine under experimental conditions. Pigs at 21 days of age were administered either a combination of two mixable monovalent vaccines or a bivalent vaccine containing PCV2 and M. hyopneumoniae. Vaccination was followed with an M. hyopneumoniae challenge at 42 days of age (−14 days post challenge, dpc) and a PCV2d challenge at 56 days of age (0 dpc). Each vaccinated and challenged group was compared with the unvaccinated and challenged group for clinical, microbiological, immunologic, and pathologic differences. Clinically, two vaccinated and challenged groups showed minimal respiratory diseases that was characterized by occasionally coughing and sneezing. A significant difference was not calculated in the average daily weight gain, nasal shedding of M. hyopneumoniae, and pathological lesions between two vaccinated and challenged groups. A combination of two monovalent vaccines mixed into a combo prior to vaccination followed by challenge resulted in increased numbers of PCV2d-specific interferon-γ secreting cells at 21 dpc and a significant reduction in PCV2d viremia at 14 dpc when compared with the ready-to-use bivalent-vaccinated and challenged groups. These results offer supporting evidence that vaccination during the weaning to finishing period against M. hyopneumoniae and PCV2 is efficacious for controlling diseases caused by these two pathogens. |
format | Online Article Text |
id | pubmed-7492382 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-74923822020-09-25 A Dual Swine Challenge With Porcine Circovirus Type 2 (PCV2) and Mycoplasma hyopneumoniae Used to Compare a Combination of Mixable Monovalent PCV2 and Monovalent M. hyopneumoniae Vaccines With a Ready-to Use PCV2 and M. hyopneumoniae Bivalent Vaccine Yang, Siyeon Oh, Taehwan Park, Kee Hwan Cho, Hyejean Chae, Chanhee Front Vet Sci Veterinary Science The present study evaluated the efficacy of swine vacciation using a combination of mixable monovalents for porcine circovirus type 2 (PCV2) and Mycoplasma hyopneumoniae against a ready-to-use bivalent vaccine under experimental conditions. Pigs at 21 days of age were administered either a combination of two mixable monovalent vaccines or a bivalent vaccine containing PCV2 and M. hyopneumoniae. Vaccination was followed with an M. hyopneumoniae challenge at 42 days of age (−14 days post challenge, dpc) and a PCV2d challenge at 56 days of age (0 dpc). Each vaccinated and challenged group was compared with the unvaccinated and challenged group for clinical, microbiological, immunologic, and pathologic differences. Clinically, two vaccinated and challenged groups showed minimal respiratory diseases that was characterized by occasionally coughing and sneezing. A significant difference was not calculated in the average daily weight gain, nasal shedding of M. hyopneumoniae, and pathological lesions between two vaccinated and challenged groups. A combination of two monovalent vaccines mixed into a combo prior to vaccination followed by challenge resulted in increased numbers of PCV2d-specific interferon-γ secreting cells at 21 dpc and a significant reduction in PCV2d viremia at 14 dpc when compared with the ready-to-use bivalent-vaccinated and challenged groups. These results offer supporting evidence that vaccination during the weaning to finishing period against M. hyopneumoniae and PCV2 is efficacious for controlling diseases caused by these two pathogens. Frontiers Media S.A. 2020-09-02 /pmc/articles/PMC7492382/ /pubmed/32984414 http://dx.doi.org/10.3389/fvets.2020.00579 Text en Copyright © 2020 Yang, Oh, Park, Cho and Chae. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Veterinary Science Yang, Siyeon Oh, Taehwan Park, Kee Hwan Cho, Hyejean Chae, Chanhee A Dual Swine Challenge With Porcine Circovirus Type 2 (PCV2) and Mycoplasma hyopneumoniae Used to Compare a Combination of Mixable Monovalent PCV2 and Monovalent M. hyopneumoniae Vaccines With a Ready-to Use PCV2 and M. hyopneumoniae Bivalent Vaccine |
title | A Dual Swine Challenge With Porcine Circovirus Type 2 (PCV2) and Mycoplasma hyopneumoniae Used to Compare a Combination of Mixable Monovalent PCV2 and Monovalent M. hyopneumoniae Vaccines With a Ready-to Use PCV2 and M. hyopneumoniae Bivalent Vaccine |
title_full | A Dual Swine Challenge With Porcine Circovirus Type 2 (PCV2) and Mycoplasma hyopneumoniae Used to Compare a Combination of Mixable Monovalent PCV2 and Monovalent M. hyopneumoniae Vaccines With a Ready-to Use PCV2 and M. hyopneumoniae Bivalent Vaccine |
title_fullStr | A Dual Swine Challenge With Porcine Circovirus Type 2 (PCV2) and Mycoplasma hyopneumoniae Used to Compare a Combination of Mixable Monovalent PCV2 and Monovalent M. hyopneumoniae Vaccines With a Ready-to Use PCV2 and M. hyopneumoniae Bivalent Vaccine |
title_full_unstemmed | A Dual Swine Challenge With Porcine Circovirus Type 2 (PCV2) and Mycoplasma hyopneumoniae Used to Compare a Combination of Mixable Monovalent PCV2 and Monovalent M. hyopneumoniae Vaccines With a Ready-to Use PCV2 and M. hyopneumoniae Bivalent Vaccine |
title_short | A Dual Swine Challenge With Porcine Circovirus Type 2 (PCV2) and Mycoplasma hyopneumoniae Used to Compare a Combination of Mixable Monovalent PCV2 and Monovalent M. hyopneumoniae Vaccines With a Ready-to Use PCV2 and M. hyopneumoniae Bivalent Vaccine |
title_sort | dual swine challenge with porcine circovirus type 2 (pcv2) and mycoplasma hyopneumoniae used to compare a combination of mixable monovalent pcv2 and monovalent m. hyopneumoniae vaccines with a ready-to use pcv2 and m. hyopneumoniae bivalent vaccine |
topic | Veterinary Science |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7492382/ https://www.ncbi.nlm.nih.gov/pubmed/32984414 http://dx.doi.org/10.3389/fvets.2020.00579 |
work_keys_str_mv | AT yangsiyeon adualswinechallengewithporcinecircovirustype2pcv2andmycoplasmahyopneumoniaeusedtocompareacombinationofmixablemonovalentpcv2andmonovalentmhyopneumoniaevaccineswithareadytousepcv2andmhyopneumoniaebivalentvaccine AT ohtaehwan adualswinechallengewithporcinecircovirustype2pcv2andmycoplasmahyopneumoniaeusedtocompareacombinationofmixablemonovalentpcv2andmonovalentmhyopneumoniaevaccineswithareadytousepcv2andmhyopneumoniaebivalentvaccine AT parkkeehwan adualswinechallengewithporcinecircovirustype2pcv2andmycoplasmahyopneumoniaeusedtocompareacombinationofmixablemonovalentpcv2andmonovalentmhyopneumoniaevaccineswithareadytousepcv2andmhyopneumoniaebivalentvaccine AT chohyejean adualswinechallengewithporcinecircovirustype2pcv2andmycoplasmahyopneumoniaeusedtocompareacombinationofmixablemonovalentpcv2andmonovalentmhyopneumoniaevaccineswithareadytousepcv2andmhyopneumoniaebivalentvaccine AT chaechanhee adualswinechallengewithporcinecircovirustype2pcv2andmycoplasmahyopneumoniaeusedtocompareacombinationofmixablemonovalentpcv2andmonovalentmhyopneumoniaevaccineswithareadytousepcv2andmhyopneumoniaebivalentvaccine AT yangsiyeon dualswinechallengewithporcinecircovirustype2pcv2andmycoplasmahyopneumoniaeusedtocompareacombinationofmixablemonovalentpcv2andmonovalentmhyopneumoniaevaccineswithareadytousepcv2andmhyopneumoniaebivalentvaccine AT ohtaehwan dualswinechallengewithporcinecircovirustype2pcv2andmycoplasmahyopneumoniaeusedtocompareacombinationofmixablemonovalentpcv2andmonovalentmhyopneumoniaevaccineswithareadytousepcv2andmhyopneumoniaebivalentvaccine AT parkkeehwan dualswinechallengewithporcinecircovirustype2pcv2andmycoplasmahyopneumoniaeusedtocompareacombinationofmixablemonovalentpcv2andmonovalentmhyopneumoniaevaccineswithareadytousepcv2andmhyopneumoniaebivalentvaccine AT chohyejean dualswinechallengewithporcinecircovirustype2pcv2andmycoplasmahyopneumoniaeusedtocompareacombinationofmixablemonovalentpcv2andmonovalentmhyopneumoniaevaccineswithareadytousepcv2andmhyopneumoniaebivalentvaccine AT chaechanhee dualswinechallengewithporcinecircovirustype2pcv2andmycoplasmahyopneumoniaeusedtocompareacombinationofmixablemonovalentpcv2andmonovalentmhyopneumoniaevaccineswithareadytousepcv2andmhyopneumoniaebivalentvaccine |